|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/4745 | (2006.01) |
| A61K 38/16 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2173349 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08827826.2 |
| Date of filing the European patent application | 2008-07-02 | |
| (97) | Date of publication of the European application | 2010-04-14 |
| (45) | Date of publication and mention of the grant of the patent | 2011-03-09 |
| (46) | Date of publication of the claims translation | 2011-06-27 |
| (86) | Number | PCT/FR2008/000943 |
| Date | 2008-07-02 |
| (87) | Number | WO 2009/024667 |
| Date | 2009-02-26 |
| (30) | Number | Date | Country code |
| 0704868 | 2007-07-05 | FR |
| (72) |
BISSERY, Marie-Christine, FR
CHIRON-BLONDEL, Marielle, FR
LEJEUNE, Pascale, FR
VRIGNAUD, Patricia, FR
|
| (73) |
Aventis Pharma S.A.,
20, avenue Raymond Aron, 92160 Antony,
FR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Priešvėžiniai deriniai, apimantys VEGF slopinantį agentą ir irinotekaną |
| ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN |
| Payment date | Validity (years) | Amount | |
| 2019-06-18 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-07-02 |